Nuclear Medicine and Molecular Imaging

The Korean Society of Nuclear Medicine (대한핵의학회)
권호 표지

Synthesis of Cyclen-Based Copper Complexes as a Potential Estrogen Receptor Ligand

에스트로젠 수용체 리간드로서 사이클렌을 기본 구조로 한 구리 착물의 합성

  • Park, Jeong-Chan (Department of Molecular Medicine Kyungpook National University School of Medicine) ;
  • Pandya, Darpan N. (Department of Molecular Medicine Kyungpook National University School of Medicine) ;
  • Jeon, Hak-Rim (Department of Molecular Medicine Kyungpook National University School of Medicine) ;
  • Lee, Sang-Woo (Department of Nuclear Medicine Kyungpook National University School of Medicine) ;
  • Ahn, Byeong-Cheol (Department of Nuclear Medicine Kyungpook National University School of Medicine) ;
  • Lee, Jae-Tae (Department of Nuclear Medicine Kyungpook National University School of Medicine) ;
  • Yoo, Jeong-Soo (Department of Molecular Medicine Kyungpook National University School of Medicine)
  • 박정찬 (경북대학교 의과대학 분자의학교실) ;
  • 달판판댜 (경북대학교 의과대학 분자의학교실) ;
  • 전학림 (경북대학교 의과대학 분자의학교실) ;
  • 이상우 (경북대학교 의과대학 핵의학교실) ;
  • 안병철 (경북대학교 의과대학 핵의학교실) ;
  • 이재태 (경북대학교 의과대학 핵의학교실) ;
  • 유정수 (경북대학교 의과대학 분자의학교실)
  • Published : 2007.08.31
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: The estrogen receptor (ER), which is over-expressed in ER-positive breast tumors, has been imaged by positron emission tomography (PET) using $[^{18}F]$ labeled estrogen ligands, especially $[^{18}F]FES$. However, $[^{18}F]$ has relatively short-lived half-life ($t_{1/2}$ =1.8 h) and the labeling yield of radio-fluorination is usually low compared with $^{64}Cu\;(t_{1/2}=12.7\;h)$. 1,4,7,10-tetraazacyclododecane (cyclen) is used to form stable metal complexes with copper, indium, gallium, and gadolinium. With these in mind, we prepared cyclen-based Cu complexes which mimic estradiol in aspect of two hydroxyl groups. Materials and Methods: 1.7-Protected cyclen, 1.7-bis (benzyloxycarbonyl)-cyclen was synthesized according to the reported procedure. After introducing two 4-benzyloxybenzyl groups at 4,10-positions, the benzyloxycarbonyl and benzyl groups were removed at the same time by hydrogenation on Pd/C to give 1,7-bis(4-hydroxybenzyl)-1,4,7,10-tetraazacyclododecane (1). Results: The prepared ligand 1 was fully characterized by $^1H,\;^{13}C$ NMR, and mass spectrometer. The synthesized ligand was reacted with copper chloride and copper perchlorate to give copper complexes $[Cu(1)]^{2+}2(CIO_4^-)\;and\;[Cu(1)Cl]^+Cl^-$ which were confirmed by high-resolution mass (FAB). Conclusion: We successfully synthesized a cyclen derivative of which two phenol groups are located on trans position of N-atoms. And, two Cu(ll) complexes of +2 and +1 overall charge, were prepared as a potential PET tracers for ER imaging.

에스트로젠 수용체 양성 유방암에서 과발현되는 에스트로젠 수용체는 $[^{18}F]FES$와 같은 $^{18}F$이 표지된 스테로이드계 에스트로젠 수용체 리간드를 사용하여 양전자방출단층촬영기로 영상을 얻을 수 있다. 반감기가 12.7시간인 $^{64}Cu$에 비해 1.8시간인 $^{18}F$은 반감기가 짧고, $^{64}Cu$로 표지 하는 경우보다 수율이 낮은 단점이 있다. 사이클렌은 구리, 인듐, 갈륨, 가돌리륨 등과 같은 금속과 안정한 착물을 형성한다. 이를 근거로 2개의 페놀 하이드록시 그룹을 가지고 있는 사이클렌을 기본구조로 한 구리 착물을 합성하였다. 재료 및 방법 : 1,7 위치에 보호기를 가지고 있는 1,7-bis(benzyloxy-carbonyl)-cyclen은 기존에 알려진 방법에 따라 합성 되어졌다. 여기에 4,10 위치에 2개의 4-benzyloxybenzyl groups을 도입한 후, Pd/C상에서의 수소화 반응으로 benzyloxycarbonyl과 benzyl groups이 모두 제거됨으로써 1,7-bis(4-hydroxybenzyl)-cyclen (1)을 성공적으로 합성할 수 있었다. 결과: 우리가 합성한 물질 1은 $^1H,\;^{13}C-NMR$ 그리고 질량분석기로 만들어졌는지 여부를 확인하였다. 이 물질들은 구리 이온과 반응하여 $[Cu(1)]^{2+}2(ClO_4)^-$와 $[Cu(1)Cl]^+Cl^-$를 형성하였고, 고분해능 FAB 질량분석기로 확인하였다. 결론: 우리는 질소원자에 trans 방향으로 2개의 페놀 그룹을 가지고 있는 cyclen 유도체를 합성하는데 성공하였고, 구리이온과 반응하여 각각 전체 전하가 +2그리고 +1인 구리 착물을 합성하였으며, 이들은 에스트로젠 수용체의 영상화를 위한 PET 추적자로 쓰일 수 있는 가능성이 있다.

Keywords

References

  1. Bigott HM, Parent E, Luyt LG, Katzenellenbogen JA, Welch MJ. Design and synthesis of functionalized cyclopentadienyl tricarbonylmetal complexes for technetium-94m pet imaging of estrogen receptors. Bioconjugate Chem 2005;16:255-64 https://doi.org/10.1021/bc049770g
  2. Eubank WB, Mankoff DA, Takasugi J, Vesselle H, Eary JF, Shanley TJ et al. 18fluorodeoxyglucose positron emission tomography to detect mediastinal or internal mammary metastases in breast cancer. J Clin Oncol 2001;19:3516-23 https://doi.org/10.1200/JCO.2001.19.15.3516
  3. Greco M, Crippa F, Agresti R, Seregni E, Gerali A, Giovanazzi R et al. Axillary lymph node staging in breast cancer by 2-fluoro-2-deoxy-d-glucose-positron emission tomography: Clinical evaluation and alternative management. J Natl Cancer Inst 2001;93:630-5 https://doi.org/10.1093/jnci/93.8.630
  4. Danforth DN, Jr., Aloj L, Carrasquillo JA, Bacharach SL, Chow C, Zujewski J et al. The role of 18F-FDG-PET in the local/regional evaluation of women with breast cancer. Breast Cancer Res Treat 2002;75:135-46 https://doi.org/10.1023/A:1019664126220
  5. Kerik Nora E, Alexanderson-Rosas E, Fermon-Schwaycer S, Ruiz-Ramirez OL, Alonso-Lopez F. Usefulness of positron tomography (PET) in lung cancer. Gac Med Mex 2004;140:525-9
  6. Nishiyama Y, Yamamoto Y, Yokoe K, Monden T, Sasakawa Y, Tsutsui K et al. Contribution of whole body FDG-PET to the detection of distant metastasis in pancreatic cancer. Ann Nucl Med 2005;19:491-7 https://doi.org/10.1007/BF02985577
  7. Isasi CR, Moadel RM, Blaufox MD. A meta-analysis of FDG-PET for the evaluation of breast cancer recurrence and metastases. Breast Cancer Res Treat 2005;90:105-12 https://doi.org/10.1007/s10549-004-3291-7
  8. Mortimer JE, Dehdashti F, Siegel BA, Katzenellenbogen JA, Fracasso P, Welch MJ. Positron emission tomography with 2- [18F]fluoro-2-deoxy-d-glucose and 16alpha-[18F]fluoro-17beta-estradiol in breast cancer: Correlation with estrogen receptor status and response to systemic therapy. Clin Cancer Res 1996;2:933-9
  9. Dehdashti F, Flanagan FL, Mortimer JE, Katzenellenbogen JA, Welch MJ, Siegel BA. Positron emission tomographic assessment of 'Metabolic flare' To predict response of metastatic breast cancer to antiestrogen therapy. Eur J Nucl Med 1999;26:51-6 https://doi.org/10.1007/s002590050359
  10. Yoshida Y, Kurokawa T, Sawamura Y, Shinagawa A, Okazawa H, Fujibayashi Y et al. The positron emission tomography with F18 17$\beta$ -estradiol has the potential to benefit diagnosis and treatment of endometrial cancer. Gynecol Oncol 2007;104:764-6 https://doi.org/10.1016/j.ygyno.2006.10.024
  11. Jonson SD, Bonasera TA, Dehdashti F, Cristel ME, Katzenellenbogen JA, Welch MJ. Comparative breast tumor imaging and comparative in vitro metabolism of 16$\alpha$-[18F] fluoroestradiol-17$\beta$ and 16$\beta$-[18F>]fluoromoxestrol in isolated hepatocytes. Nucl Med Biol 1998;26:123-30 https://doi.org/10.1016/S0969-8051(98)00079-1
  12. Kang WJ, Kang H-J, Kim H-S, Chung J-K, Lee MC, Lee DS. Tissue distribution of $^{18}F-FDG-labeled peripheral hematopoietic stem cells after intracoronary administration in patients with myocardial infarction. J Nucl Med 2006;47:1295-301
  13. Smith SV. Molecular imaging with copper-64. J Inorg Biochem 2004;98:1874-901 https://doi.org/10.1016/j.jinorgbio.2004.06.009
  14. Kovacs ZS, A.D. A general synthesis of 1,7-disubstituted 1,4,7,10-tetraazacyclododecanes. J Chem Soc Chem Commun 1995:185-6
  15. Minutolo F, Antonello M, Bertini S, Ortore G, Placanica G, Rapposelli S et al. Novel estrogen receptor ligands based on an anthranylaldoxime structure: Role of the phenol-type pseudocycle in the binding process. J Med Chem 2003;46:4032-42 https://doi.org/10.1021/jm0308390
  16. Muthyala RS, Sheng S, Carlson KE, Katzenellenbogen BS, Katzenellenbogen JA. Bridged bicyclic cores containing a 1,1-diarylethylene motif are high-affinity subtype-selective ligands for the estrogen receptor. J Med Chem 2003;46:1589-602 https://doi.org/10.1021/jm0204800
  17. Muthyala RS, Carlson KE, Katzenellenbogen JA. Exploration of the bicyclo[3.3.1]nonane system as a template for the development of new ligands for the estrogen receptor. Bioorg Med Chem Lett 2003;13:4485-8 https://doi.org/10.1016/j.bmcl.2003.08.061
  18. Jonson SD, Welch MJ. Pet imaging of breast cancer with fluorine-18 radiolabeled estrogens and progestins. Q J Nucl Med 1998;42:8-17
  19. Linden HM, Stekhova SA, Link JM, Gralow JR, Livingston RB, Ellis GK et al. Quantitative fluoroestradiol positron emission tomography imaging predicts response to endocrine treatment in breast cancer. J Clin Oncol 2006;24:2793-9 https://doi.org/10.1200/JCO.2005.04.3810
  20. Arterburn JB, Corona C, Rao KV, Carlson KE, Katzenellenbogen JA. Synthesis of 17-$\alpha$-substituted estradiol-pyridin-2-yl hydrazine conjugates as effective ligands for labeling with alberto's complex fac-[re(oh2)3(co)3]+ in water. J Org Chem 2003;68:7063-70 https://doi.org/10.1021/jo034780g
  21. Luyt LG, Bigott HM, Welch MJ, Katzenellenbogen JA. 7$\alpha$- and 17$\alpha$-substituted estrogens containing tridentate tricarbonyl rhenium/ technetium complexes: Synthesis of estrogen receptor imaging agents and evaluation using micropet with technetium-94m. Bioorg Med Chem 2003;11:4977-89 https://doi.org/10.1016/j.bmc.2003.09.004
  22. Vijaykumar D, Al-Qahtani MH, Welch MJ, Katzenellenbogen JA. Synthesis and biological evaluation of a fluorine-18 labeled estrogen receptor-a selective ligand: [$^{18}F] propyl pyrazole triol. Nucl Med Biol 2003;30:397-404 https://doi.org/10.1016/S0969-8051(02)00446-8
  23. Endo Y, Iijima T, Yamakoshi Y, Yamaguchi M, Fukasawa H, Shudo K. Potent estrogenic agonists bearing dicarba-closo- dodecaborane as a hydrophobic pharmacophore. J Med Chem 1999;42: 1501-4 https://doi.org/10.1021/jm9900725
  24. Reichert DE, Yoo J. unreported results
  25. Yoo J, Reichert DE, Welch, MJ. Comparative in vivo behavior studies of cyclen-based copper-64 complexes: Regioselective synthesis, x-ray structure, radiochemistry, log p, and biodistribution. J Med Chem 2004;47:6625-37 https://doi.org/10.1021/jm0496990
  26. Yoo J, Reichert DE, Welch, MJ. Regioselective n-substitution of cyclen with two different alkyl groups: Synthesis of all possible isomers. Chem Commun 2003:766-7
  27. Fredriksson A, Stone-Elander S. Rapid microwave-assisted cleavage of methyl phenyl ethers: New method for synthesizing desmethyl precursors and for removing protecting groups. J Label Compd Radiopharm 2002;45:529-38 https://doi.org/10.1002/jlcr.577
  28. Gates M, Tschudi G. Synthesis of morphine. J Am Chem Soc 1956;78:1380-93 https://doi.org/10.1021/ja01588a033
  29. Kulkarni PP, Kadam AJ, Mane RB, Desai UV, Wadgaonkar PP. Demethylation of methyl aryl ethers using pyridine hydrochloride in solvent-free conditions under microwave irradiation. J Chem Res 1999:394-5